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Contamination of drinking-water by arsenic
in Bangladesh: a public health emergency
Allan H. Smith,1 Elena O. Lingas,2 & Mahfuzar Rahman3
The contamination of groundwater by arsenic in Bangladesh is the largest poisoning of a population in history, with
millions of people exposed. This paper describes the history of the discovery of arsenic in drinking-water in
Bangladesh and recommends intervention strategies. Tube-wells were installed to provide ‘‘pure water’’ to prevent
morbidity and mortality from gastrointestinal disease. The water from the millions of tube-wells that were installed
was not tested for arsenic contamination. Studies in other countries where the population has had long-term
exposure to arsenic in groundwater indicate that 1 in 10 people who drink water containing 500 mg of arsenic per
litre may ultimately die from cancers caused by arsenic, including lung, bladder and skin cancers. The rapid
allocation of funding and prompt expansion of current interventions to address this contamination should be
facilitated. The fundamental intervention is the identification and provision of arsenic-free drinking water. Arsenic is
rapidly excreted in urine, and for early or mild cases, no specific treatment is required. Community education and
participation are essential to ensure that interventions are successful; these should be coupled with follow-up
monitoring to confirm that exposure has ended. Taken together with the discovery of arsenic in groundwater in
other countries, the experience in Bangladesh shows that groundwater sources throughout the world that are used
for drinking-water should be tested for arsenic.
Keywords: Bangladesh; arsenic poisoning, prevention and control; arsenic poisoning, therapy; water pollution,
chemical, prevention and control; water treatment; environmental monitoring.
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Introduction
Bangladesh is grappling with the largest mass
poisoning of a population in history because ground-
water used for drinking has been contaminated with
naturally occurring inorganic arsenic. It is estimated
that of the 125 million inhabitants of Bangladesh
between 35 million and 77 million are at risk of
drinking contaminated water (1, 2). The scale of this
environmental disaster is greater than any seen
before; it is beyond the accidents at Bhopal, India,
in 1984, and Chernobyl, Ukraine, in 1986. This paper
suggests guidelines for responding when a popula-
tion is exposed to arsenic, and it is based on
information from several visits to Bangladesh made
by Allan H. Smith as a consultant for the World
Health Organization between 1997 and 1998 (3–5).
In 1983, the first cases of arsenic-induced skin
lesions were identified by K.C. Saha then at the
Department of Dermatology, School of Tropical
Medicine in Calcutta, India (6). The first patients seen
were from West Bengal, but by 1987 several had
already been identified who came from neighbouring
Bangladesh. The characteristic skin lesions included
pigmentation changes, mainly on the upper chest,
arms and legs, and keratoses of the palms of the
hands and soles of the feet (Fig. 1). After ruling out
other causes, water sources used by the patients were
analysed, and the diagnosis of arsenic-caused disease
was confirmed. The primary drinking-water sources
for the patients were tube-wells, which drew water
from underground aquifers (Fig. 2) (6).
Tube-wells have been used in Bangladesh since
the 1940s (7). However, the problem of arsenic-
contaminated water has only recently come to light
due to the increasing number of tube-wells used over
the past 20 years and the subsequent increase in the
number of individuals drinking from them. Histori-
cally, surface water sources in Bangladesh have been
contaminated with microorganisms, causing a sig-
nificant burden of disease and mortality. Infants and
children suffered from acute gastrointestinal disease
resulting from bacterial contamination of stagnant
pond water. Consequently, during the 1970s the
United Nations Children’s Fund (UNICEF) worked
with theDepartment of PublicHealth Engineering to
install tube-wells to provide what was presumably a
safe source of drinking-water for the population.
These wells consist of tubes that are 5 cm in diameter
that are inserted into the ground at depths of usually
less than 200m. The tubes are then cappedwith a cast
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iron or steel hand pump. At the time the wells were
installed, arsenic was not recognized as a problem in
water supplies, and therefore standard water testing
procedures did not include tests for arsenic (7).
During the 1980s, UNICEF’s support for
installing tube-wells decreased because the private
sector was able to supply and install millions more of
them (7). By 1997, UNICEF indicated in its country
report for Bangladesh that it had surpassed its goal of
providing 80% of the population by 2000 with access
to ‘‘safe’’ drinking-water in the form of tube-wells,
ring-wells and taps (8). Presently, three out of four
tube-wells in Bangladesh are privately owned (7).
Extent of exposure in the population
In Bangladesh, arsenic contamination of water in
tube-wells was confirmed in 1993 in the Nawabganj
district (1). Further testing was done in the following
years; this included investigations by the Department
of Occupational and Environmental Health of the
National Institute of Preventive and Social Medicine.
Results from various laboratories were collated in a
WHO country situation report in 1996 (9). The
institutions that provided results included the
Jadavpur University in Calcutta, India, the Bangla-
desh Atomic Energy Commission, the Department
of Public Health Engineering’s laboratories in the
Khulna and Rajshahi districts, and the National
Institute of Preventive and SocialMedicine inDhaka.
Altogether, 400 measurements were presented in the
report, although contamination in some wells was
measured by more than one laboratory. In about half
of the measurements concentrations were above
50 mg/l (9), which is clearly in excess of the
maximum level recommended by WHO of 10 mg/l
(10) and greater than the maximum level of 50 mg/l
permitted in Bangladesh (7).
To raise awareness of the seriousness of the
arsenic problem inWest Bengal and to draw attention
to the need for studies in Bangladesh, a conference
was convened in 1995 by D. Chakraborti and the
School of Environmental Studies of Jadavpur
University in Calcutta (11). In the years after the
conference, the extent of the problem in Bangladesh
has become clearer through additional surveys of the
water and population, many of which were led by
Chakraborti.
A study conducted in the Rajarampur village of
the Nawabganj district, by the National Institute of
Preventive and Social Medicine and the School of
Environmental Studies, found that 29% of the
294 tube-wells tested had arsenic concentrations
greater than 50 mg/l (12). Between September 1996
and June 1997, a survey was jointly conducted by
Dhaka Community Hospital and the School of
Environmental Studies. An examination of 265 wells
in Samta village in the Jessore district found that
about 91% of the wells had arsenic concentrations
higher than 50mg/l (13). In 1998, a BritishGeological
Survey of 41 districts collected 2022 water samples
— 35% were found to have arsenic concentrations
above 50 mg/l (Table 1) and 8.4% were above
300 mg/l (14). Based on population density mea-
sured in 1998, this group estimated that the number
of people exposed to arsenic concentrations above
50 mg/l was about 21 million. This number would be
approximately doubled ifWHO’s standard of 10mg/l
were adopted. Further studies conducted by the
Table 1. Percentage of groundwaters surveyed in 1998 by the
British Geological Survey with arsenic levels over 50 mg/l
District % of District % of
groundwaters groundwaters
surveyed surveyed
Bagerhat 66 Madaripur 93
Barisal 63 Magura 19
Brahmanbaria 38 Manikganj 15
Chandpur 96 Meherpur 60
Chittagong 20 Moulvibazar 12
Chuadanga 44 Munshiganj 83
Comilla 65 Narail 43
Cox’s Bazar 3 Narayanganj 24
Dhaka 37 Nawabganj 4
Faridpur 66 Noakhali 75
Feni 39 Pabna 17
Gopalganj 94 Pirojpur 24
Jessore 51 Rajbari 24
Jhalakati 14 Rajshashi 6
Jhenaidah 26 Satkhira 73
Khulna 32 Shariatpur 80
Kushtia 28 Sylhet 19
Lakshmipur 68
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School of Environmental Studies and the Dhaka
Community Hospital found that 59% of the
7800 groundwater samples had arsenic concentra-
tions greater than 50 mg/l (15).
In 1997 a project designed to establish the
extent of the problem in a sample population was
authorized by the government of Bangladesh. Two
hundred villages that had already been identified as
having arsenic-contaminated tube-wells were sur-
veyed by the Rapid Action Programme. These
villages had a combined population of 469 424.
About 62% of the 32 651 tube-wells sampled had
concentrations greater than 100 mg/l (16).
Surveys of the effects on the population’s
health have occurred concurrently with the previous
studies of groundwater contamination. From De-
cember 1996 to January 1997, a three-week survey
was conducted by the Dhaka Community Hospital
and the School of Environmental Studies. The survey
team visited 18 affected districts. Of the 1630 adults
and children examined, 57.5% of them had skin
lesions due to arsenic poisoning (11). In another
study, approximately one-third of the 7364 patients
examined had skin lesions due to arsenic (17).
The population of the 42 affected districts was
76.9 million. These studies do not imply that the
entire population is drinking contaminated water. A
recent report from theWorld Bank has estimated that
20 million inhabitants of Bangladesh may be drinking
arsenic-contaminated water (18).
In the 200 villages surveyed by the Rapid Action
Programme, 1802 of 469 424 people were found to
have arsenic-induced skin lesions. During the same
period a more detailed study of four villages with
arsenic-contaminated tube-wells was conducted, and
1481 adults were interviewed and examined (19). Of
these, 430 were found to have skin lesions.
The actual extent of the contamination and the
number of people with skin diseases caused by
arsenic might be many times higher than is currently
estimated. For comparison, it has been estimated that
in West Bengal the number of people exposed to
arsenic is 1.5 million, and one estimate of the number
of patients with arsenicosis exceeds 200 000 (20, 21).
Since the estimate of those who may be drinking
arsenic-contaminated water in Bangladesh is in the
tens of millions, it is reasonable to expect that unless
exposure ends the number of people with arsenicosis
will eventually far exceed the number observed in
West Bengal. Although all wells and all villagers have
not been systematically tested and examined, this
should not delay action. The evidence that has
accumulated since 1997 has only confirmed that this
is a public health threat of great magnitude (Box 1).
Long-term health effects of exposure
The health effects of ingesting arsenic-contaminated
drinking-water appear slowly (Box 2). For this reason,
a more important issue than the number of patients
who currently have arsenic-caused diseases is the
number who will develop these diseases in the future
as a result of past and continuing exposure to arsenic.
Large numbers of tube-wells were installed in
Bangladesh approximately 5 to 20 years ago. If the
population continues to drink arsenic-contaminated
water, then amajor increase in the number of cases of
diseases caused by arsenic may be predicted.
Skin lesions
The latency for arsenic-caused skin lesions (i.e., the
time from first exposure to manifestation of disease),
in particular keratoses, is typically about 10 years (22).
In the 1997 consultancy, it was found that the
youngest individuals with skin lesions caused by
arsenic were about 10 years old. Other studies have
shown that skin lesions also occur in children younger
than 10 years (23). It was also found that in adults,
exposures commenced approximately 10 years
before they stated the skin lesions began to appear.
In some instances, the apparent latency for the
appearance of skin lesions from the time of first
exposure to contaminated water from the tube-well
currently in use was much shorter, but as no
measurements were available for water from pre-
viously used tube-wells, a short latency from first
exposure could not be inferred. However, latency
that is shorter or longer than 10 years may occur, and
the rapidity of the appearance of skin lesions appears
to be dose dependent (22). Further studies of the
latency and patterns of occurrence of skin lesions are
needed and these will require careful interviewing of
participants about their current and past exposures.
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Cancer
Skin cancer. Small numbers of cases of skin cancer
have started to appear. Since the typical latency is
more than 20 years after the beginning of exposure,
the fact that only a small number have been found
provides little reassurance about the future incidence
of skin cancer. A study of a large population in
Taiwan found a clear dose-response relationship
between arsenic concentrations in drinking-water
and the prevalence of skin cancer (24). In this study,
the average concentration of arsenic in water was
about 500 mg/l, and by age 60 more than 1 in 10 had
developed skin cancer. The lifetime risk of develop-
ing skin cancer from the intake of 1 mg . kg body
weight -1 . day -1 (roughly equivalent to 1 litre per day
at concentrations of 50 mg/l) of arsenic in water
ranges from 1 per 1000 to 2 per 1000 (25). Though
large numbers of skin cancers have been reported in
Taiwan, the future burden of arsenic-caused skin
cancer in Bangladesh is uncertain. Differences in
susceptibility between the populations of Taiwan and
Bangladeshmay exist that only time and further study
will identify. However, as yet there is no evidence to
indicate that the long-term risks of skin cancer would
be any lower in Bangladesh than in Taiwan.
Mortality from internal cancers. In other
countries, the main causes of death associated with
chronic ingestion of arsenic in drinking-water are
internal cancers; skin cancers are not usually fatal if
treated appropriately. Dramatic increases in mortality
from internal cancers have been reported in Taiwan
(26–28) and Chile (29). In Taiwan, populations
exposed to high concentrations of arsenic in their
drinking-water, containing an average of 800 mg/l of
arsenic, had estimates of their relative risk of bladder
cancer in the order of 30–60 (27, 30). In Region II of
northern Chile, 5–10% of all deaths occurring among
those over the age of 30 were attributable to arsenic-
caused internal cancers, in particular bladder cancer
and lung cancer (29). Average exposures were in the
order of 500 mg/l (0.5 mg/l) over 10–20 years;
exposure decreased in subsequent years after
remediation efforts were introduced (29). Long
latency was apparent, and increases in mortality
continued for 40 years after the highest exposures
began (29). In Argentina, a mortality study in the
arsenic-exposed region of Co´rdoba found increased
risks of bladder and lung cancer among men and
women from 1986 to 1991, although concentrations
were lower (average 178 mg/l) than in Taiwan and
Chile (31, 32).
Using the current US Environmental Protec-
tion Agency standard of 50 mg/l, it has been
estimated that the lifetime risk of dying from cancer
of the liver, lung, kidney or bladder while drinking
1 litre a day of water containing arsenic at this
concentration could be as high as 13 per 1000 persons
exposed (30). Using the same methods, the risk
estimate for 500 mg/l of arsenic in drinking-water
would be 13 per 100 people (33). In its latest
document on arsenic in drinking-water, the US
National Research Council concluded that exposure
to 50 mg/l could easily result in a combined cancer
risk of 1 in 100 (34).
Although specific estimates of the current and
future health effects of arsenic exposure are
uncertain, in the case of Bangladesh it can be inferred
that since there are many people who currently have
skin lesions caused by ingesting arsenic, many more
cases will occur if exposure continues; based on what
is known about the relationship between ingestion
and the development of internal cancers, it is
reasonable to expect marked increases in mortality
from internal cancers once sufficient latency has been
reached. It is also reasonable to expect marked
increases in the incidence of the other health effects
listed in Box 2.
Classifying arsenic in drinking-water
as a public health emergency
Classifying contamination of groundwater by arsenic
as a public health emergencywould facilitate the rapid
allocation of funding and the prompt expansion of
interventions. Issues central to the argument in
favour of an emergency response are listed in Box 3.
Arsenic exposure may be mitigated in a
relatively straightforward manner. However, in
Bangladesh the situation is complicated by the weak
Box 1. Magnitude of arsenic poisoning in
Bangladesh
Population of Bangladesh: 125 million
Total population in regions where
some wells are known to be
contaminated: 35–77 million
Maximum concentration of arsenic
permitted in drinking-water accord-
ing to WHO recommendations: 10 mg/l
Maximum concentration allowed
in Bangladesh: 50mg/l (similar to many
countries worldwide)
Number of tube-wells sampled by
the British Geological Survey (1998): 2022
– Proportion of wells with arsenic
concentrations >50 mg/l: 35%
– Proportion of wells with arsenic
concentrations >300 mg/l: 8.4%
Box 2. Long-term health effects of exposure to arsenic
Skin lesions
Skin cancer
Internal cancers
Bladder
Kidney
Lung
Neurological effects
Hypertension and cardiovascular disease
Pulmonary disease
Peripheral vascular disease
Diabetes mellitus
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economy and the need to rely largely on external aid
to resolve public health problems. There are also
significant difficulties in communication and trans-
portation within the country that create obstacles for
community education and intervention programmes.
Nevertheless, in contrast to diseases like malaria,
cholera and tuberculosis, which require a more
complex public health response, the response to
arsenic contamination is clear-cut: provide arsenic-
free water. Although the precise extent of the
problem is not known, this does not invalidate the
need for an emergency response. The extent of the
problem may be more accurately determined during
the course of the response. The health of the
population is at risk and relief cannot wait for further
surveys.
Emergency intervention programme
The core activity of an emergency action plan for this
threat to human health should be rapid case
ascertainment and immediate provision of arsenic-
free water. The objectives of such a plan should be as
follows: (1) to identify all cases of arsenicosis in
Bangladesh; (2) the immediate identification of an
interim source of arsenic-free water and commence-
ment of implementation of the long-term solution;
(3) tomonitor patients’ progress and compliancewith
interim water treatment until a long-term water
source has been identified and made available; and
(4) to provide care for patients, including vitamin
supplementation, lotions for patients with keratoses
and treatment of infections.
Strategies to reduce exposure
A short-term strategy might include five responses.
Firstly, identify nearby tube-wells that have water
with a low arsenic content. Secondly, provide a water
filter for each household. A candle filtration system is
available. It is easy to use and maintain, and this
contributes to good compliance. The disadvantage is
that the arsenic-loaded candles must be disposed of
but this should not be a problem if the filter is used as
an interim solution for a few months only. Units
designed to be attached to tube-wells to remove
arsenic are being tested and may prove to be an
effective short-term alternative. Thirdly, provide
chemicals to be used daily to remove arsenic from
household drinking-water. The small packet of
chemicals that can be mixed in water and left to
stand overnight is very cheap and is simple to
transport. The disadvantages of this strategy include
the need for daily or close to daily use and the need to
dispose of the sludge after each treatment. Whether
people will use these chemicals needs to be evaluated.
Fourthly, use surface water sources that have been
treated by filtration and chlorination. Fifthly, close
highly contaminated wells when a temporary water
source has been identified.
Field kits should be used if they can detect
contamination of water containing 100 mg/l or more
of arsenic. It would be better still if they could reliably
detect 50 mg/l. Since WHO’s recommended max-
imum concentration of 10 mg/l cannot be accurately
measured with a field kit, it has been proposed that
samples should be sent to laboratories for testing.
However, sending samples to a laboratory can cause
delays to programmes in the affected communities.
In contrast, using field kits that can measure
concentrations of 50 mg/l provides instantaneous
results and facilitates prompt action to find an
alternative water source if needed (35).
Some interventions that involve major actions,
such as treating water with chemical packets, are
inexpensive as far as materials are concerned but are
expensive in terms of training, monitoring and
education. Treating water with alum or allowing it
to stand so that arsenic settles in iron-rich water is not
advisable since reducing exposure in the short-term
by the order of 50% (compared with a reduction of
80–90%) does little to alter the cumulative dose on
which arsenic disease risks are based, and it may delay
the planning for an arsenic-free solution. For
example, if a short-term intervention reduces arsenic
concentrations in water by 50% for 2 years but in the
process uses resources and reduces motivation, thus
delaying the provision of arsenic-free water for 1 year,
then there has been no health benefit from the
resources used because there has been no reduction
in the cumulative intake of arsenic.
Further work is needed in planning long-term
intervention measures. For the moment, unless there
are local contraindications, the sinking of deep tube-
wells (below 200 m) and dug wells or ring-wells
(20–30 m) appear to be successful options. Deep
tube-wells, however, have potential problems and
must be installed carefully to avoid cross-contamina-
tion from shallower aquifers. Another potential long-
term solution, rain-water harvesting, also warrants
attention because of the high annual rainfall in the
Box 3. Arsenic-contaminated drinking-water: a
public health emergency
. Arsenic exposure in Bangladesh is widespread and
involves thousands of wells
. Estimates indicate that at least 100 000 cases of skin
lesions caused by arsenic have occurred and there may be
many more
. If exposure continues, skin lesions will continue to occur
. Skin lesions are unpleasant and may be debilitating
. Skin lesions are occurring in children aged 10 years and
younger
. Large numbers of cancers are predicted to occur in the
future, including fatal internal cancers
. The cause is known: each day of continued exposure
increases the risk of morbidity and death
. Sustained drinking of water containing 500mg/l of arsenic
may result in 1 in 10 people dying from arsenic-related
cancers
. Unlike other major health problems experienced in
Bangladesh, arsenic-caused diseases can be eradicated
at relatively low cost
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region. However, in our view, arsenic removal
treatment systems have serious problems with
maintenance and the disposal of arsenic sludge, and
cannot be recommended as long-term solutions.
Relief from continuing arsenic ingestion can-
not wait until the necessary investigations are
completed for the long-term planning of alternative
water sources. From a public health standpoint,
emergency interventions are best accomplished
through an existing technology which has already
been tested and is known to be well received at the
population level. Interventions requiring adjustments
to an existing behaviour (for example, using a
different tube-well that is a little further away) are
generally more effective than introducing interven-
tions of a new or unfamiliar nature (for example,
using chemical packets to treat household water or
harvesting rain water during part of the year and using
another source for the rest of the year). This is
particularly true in the case of arsenic poisoning
because people might find it difficult to believe that
crystal clear water is responsible for disease and
death. The use of alternative, non-contaminated,
shallow tube-wells, and the insertion of dug wells or
sinking of deep tube-wells where there are no
uncontaminated shallow wells, would appear to be
the interventions that best satisfy these two criteria
for an emergency programme.
Simple diagnosis in the field
The diagnosis of disease caused by chronic ingestion
of inorganic arsenic is usually straightforward. The
most common signs are hyperpigmentation, espe-
cially on the upper chest and arms, and keratoses on
the palms and soles of the feet (Fig. 1). Keratoses on
the palms of hands and soles of the feet are very
characteristic (except in very mild early cases). The
diagnosis is confirmed if a patient with keratoses and
hyperpigmentation is found to have been drinking
water with a high arsenic content over a period of
years.
The diagnosis of arsenic-caused disease is
facilitated by the ability to rapidly assess concentra-
tions of arsenic in water. The ideal test would be one
that could be done immediately in the field. Since the
purpose of such tests is to detect significant
exposure, the methods used do not need to be able
to detect low concentrations nor do they need to have
high precision. For diagnostic purposes, it would be
sufficient to detect concentrations greater than
50 mg/l or 100 mg/l. At the high concentrations
often encountered in Bangladesh, precision could be
relatively low. For example, if a true water concen-
tration were 350 mg/l, for initial diagnostic purposes
it would be sufficient to know that the concentration
was in the range 200–600 mg/l. A field kit that uses
locally made materials, which was designed by the
National Institute of Preventive and Social Medicine
in Bangladesh, has received good evaluations in a
programme sponsored by WHO (5).
High accuracy and precision in water measure-
ments make little sense when human exposure also
depends on the volume of water ingested. Even with
careful interviewing for 10 to 15 minutes, the volume
of water ingested from a particular source over the
years can only be estimated within broad ranges. If a
patient drank about 2–4 l of arsenic-contaminated
water per day over the past 10 years, it is clear that the
current concentration of arsenic in his or her
drinking-water does not have to be measured with
a precision of+5%.
Many other signs and symptoms have been
reported in those patients who have chronically
ingested arsenic. In studies in West Bengal, respira-
tory symptoms, crepitations and liver enlargement
are prevalent (36, 37). However, these signs are non-
specific and are typically accompanied by hyper-
pigmentation or keratoses, or both.
Since the diagnosis of arsenicosis can usually be
established by simple examination of the skin, there is
no need for expensive tests or for the typical patient,
who may be free from other complications, to be
admitted to hospital. Examination of the patient in
the field, supplementedwith an analysis of the arsenic
content of water samples, can suffice. The examina-
tion for skin lesions itself does not require special
skills or medical training.
At very high concentrations, acute symptoms
may occur long before skin lesions appear. The most
common early symptoms are gastrointestinal, includ-
ing diarrhoea and abdominal pain (10). Peripheral
neuropathy may occur. Such non-specific signs and
symptoms in a patient living in an arsenic-exposed
region should alert the physician or nurse to
investigate the sources of drinking-water.
Skin cancer caused by arsenic is usually
accompanied by non-malignant skin effects. The
internal cancers caused by arsenic have no special
features and no special diagnostic procedures can be
used.
Treatment
The basic treatment is to supply the patient with
drinking-water that is free from arsenic. This is the
first priority. Indeed, in the absence of good evidence
for the effectiveness of other treatments, the second
priority is to continue providing arsenic-free water,
and the third priority is to monitor patients to ensure
that they remain unexposed to arsenic. Providing
arsenic-free water reduces the risk of further
complications and disease caused by arsenic. There
are no well-designed studies to show whether
cessation of exposure leads to improvement in skin
keratoses. Thus far, anecdotal interviews of patients
suggests that mild to moderate keratoses do improve
with cessation of exposure.
Chelation. Some physicians have been giving
chelation therapy to arsenic patients in West Bengal
and Bangladesh. The objective of chelation therapy is
to provide the patient with a chemical to which
arsenic binds strongly, and is then excreted in urine.
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Providing such treatment could remove large stores
of arsenic from the body in a matter of hours.
There are several problems with chelation
therapy in cases of chronic arsenic exposure. The first
is related to the observation that arsenic is excreted
rapidly even without chelation therapy. Most of the
readily available arsenic in the body will be excreted in
the urine within 1 week (38, 39). The question is
whether chelation might remove arsenic which is, for
example, bound in the skin and which might without
chelation only be removed slowly. This is possible but
exposure to arsenic generally occurs over many years,
and chelation may make little difference to the
cumulative dose of arsenic that patients have
received. Thus, chelation therapy is unlikely to
reduce the future risk of cancer. Whether it might
improve keratoses more rapidly than simply stopping
exposure is unknown. This idea has some plausibility
but its effectiveness has not been established.
The second problem with chelation therapy is
the lack of any clinical trials that found evidence of its
effectiveness (40). When exposure to arsenic ceases,
improvement in skin lesions might occur. Thus, if a
patient improves after chelation therapy it could be
due to the cessation of exposure alone or to both
cessation and chelation therapy. Finding that patients
improve after chelation therapy does not provide
evidence that the therapy itself is effective.
The third problem with chelation therapy is
that it is of no benefit if the patient continues to drink
contaminated water after treatment, and it may give
the false impression that effects can be treated
despite continued exposure. Thus, chelation therapy
should not be used routinely, although careful
controlled studies of chelation therapy in patients
with keratoses and other arsenic effects should
perhaps be undertaken.
Nutrition. Since evidence from Taiwan sug-
gests that some nutritional factorsmaymodify cancer
risks associated with arsenic (41), it has been
proposed that providing vitamins and improving
nutrition may be of benefit to patients. In particular,
vitamin A is known to be beneficial in the
differentiation of various tissues, particularly the
skin. If the doses given are not excessive, there are
other nutritional benefits to providing vitamins,
particularly in populations that may have inadequate
levels of micronutrients. For these reasons, it is
recommended that all patients with skin lesions be
provided multivitamin tablets and that research
projects be undertaken to establish whether or not
they are effective for patients with arsenicosis.
Other considerations. Advanced keratoses on
the palms of the hands and soles of the feet are
extremely debilitating, and superimposed infections,
such as fungal infections, may cause serious
problems. Providing moisturizing lotions and treat-
ment for infections may be beneficial and should be
part of routine care in advanced cases. These topics
should be systematically studied. Arsenic is a
probable contributor to causation of diabetes
mellitus (42, 43). For this reason, urinary glucose
should be tested in all patients with arsenicosis, and
appropriate treatment and monitoring should be
started if necessary. Patients’ blood pressure should
also be monitored since arsenic exposure may induce
hypertension (44).
Ongoing monitoring
Despite some attempts to educate communities,
large numbers of people continue to drink from the
same contaminated water sources used before the
introduction of an intervention. Other water testing
programmes carried out with the aid of community
health workers have indicated that community
awareness increases as a consequence of the
programmes (45). Therefore, continuing education
and monitoring needs to be integrated into existing
health services, whether governmental or non-
governmental.
Guidelines for programmes aimed at continu-
ing to educate and monitor populations exposed to
arsenic should include advising these populations
about the arsenic in drinking-water, the sources of
arsenic-free water, and the importance of compliance
with treatment programmes, including nutrition.
Field workers should make monthly home visits to
those villages that are most seriously affected. Field
workers should be equipped with a continuing
education plan, topical creams for keratoses, vitamin
tablets, and medicines for fungal infections.
Patients should be advised where to seek
additional medical care if needed. The physicians and
paramedical staff serving the most affected areas
should receive special training in understanding
arsenic toxicity, disease outcomes and treatment
options.
The possibility of continuing exposure to
arsenic through water or food should be monitored
through the testing of urine samples. Currently, there
is no recommended field kit for urine testing.
Therefore, samples should be sent to a reference
laboratory equipped to measure arsenic in biological
specimens.
In addition to obtaining biological samples,
field workers should interview patients and ask them
where they currently get their drinking-water to
assess whether they are complying with the inter-
vention or whether they are continuing to put their
health at risk by drinking contaminated water. These
regular interviews will provide opportunities for
ongoing health education.
Lessons to be learned
The discovery of arsenic contamination of ground-
water in many nations, including Argentina, Chile,
China, India, Mexico, Taiwan, Thailand, the United
States and, now, Bangladesh shows that this is a
global problem. All groundwater sources used for
drinking-water should be tested for arsenic. A
retrospective look at the situation in Bangladesh is
instructive in that a declaration of a public health
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emergency might have expedited a more rapid
response to the problem. In the three years after
the original consultancy in Bangladesh for WHO
(3–5), the rapid intervention team has only reached a
few hundred villages. Millions of wells and people
remain to be tested and examined. This experience in
Bangladesh has reinforced the importance of using
organizations and systems that are already in place in
the affected area. When a rapid response to a health
emergency is needed, it is not the time to reorganize
or implement completely new systems. Rather, it is
the time to take advantage of existing governmental
and nongovernmental organizations, which already
have contacts in the field and can thus respond
quickly. The rapidity of the response is crucial — the
longer the exposure continues, the greater the
likelihood of disease.
Contamination of drinking-water with arsenic
further illustrates the difficulties of community-
based interventions. It is likely that a single visit to a
village, during which the water is tested and the
nearest well painted red, will not have a long-term
impact on the behaviour of members of the
community, particularly if none of the villagers has
any signs of arsenic-caused disease. Habits are
difficult to break; one visit will not be convincing
when the villagers look at the clear, clean water.
Follow-up monitoring and education are integral to
sustaining the impact of the first intervention and to
safeguarding the population’s health.
Most importantly, the arsenic contamination of
groundwater in Bangladesh has indicated that
delaying action in an attempt to be thorough in
research and long-term planning can be a mistake.
Long-term solutions will likely have to be tailored to
local environments, and it is counterproductive to
defer immediate action until the long-term alter-
natives are completely designed. The cause of
arsenicosis is clear and continuing exposure increases
the risk of non-fatal outcomes and death; these
diseases can be eradicated at relatively low cost. In
such a situation, the worst thing that can possibly be
done is nothing. n
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Re´sume´
Contamination de l’eau de boisson par de l’arsenic au Bangladesh : une urgence
de sante´ publique
La contamination des nappes phre´atiques par de
l’arsenic au Bangladesh est a` ce jour la plus grande
intoxication d’une population recense´e au cours de
l’histoire, des millions de personnes ayant e´te´ expose´es a`
l’arsenic. Le pre´sent article de´crit la de´couverte au
Bangladesh de cette contamination de l’eau de boisson
par l’arsenic et recommande des strate´gies d’interven-
tion. Au de´but des anne´es 70, on a installe´ des puits
tube´s afin de fournir de l’« eau pure » et de pre´venir la
morbidite´ et la mortalite´ dues aux maladies gastrointes-
tinales. L’eau ve´hicule´e par les millions de puits tube´s qui
ont e´te´ installe´s n’a pas e´te´ teste´e pour y rechercher une
contamination par l’arsenic, car on n’e´tait pas conscients
a` l’e´poque des proble`mes de contamination.
En 1998, une enqueˆte re´alise´e par la British
Geological Survey portant sur 41 districts a permis de
recueillir 2022 e´chantillons d’eau – dont 35 % se sont
ave´re´s posse´der des concentrations d’arsenic supe´rieures
a` 50 mg/l (la concentration maximum autorise´e au
Bangladesh) et 8,4 % des concentrations supe´rieures a`
300 mg/l. Compte tenu de la densite´ de la population
dans ce pays en 1998, la British Geological Survey a
estime´ que le nombre de personnes expose´es a` des
concentrations d’arsenic supe´rieures a` 50 mg/l e´tait
d’environ 21 millions. Il faudrait multiplier ce nombre a`
peu pre`s par deux si l’on adoptait la concentration
maximum recommande´e par l’OMS, qui est de 10 mg/l.
Les effets sur la sante´ de l’ingestion d’eau
contamine´e par l’arsenic se manifestent lentement. Pour
cette raison, il est important de recenser le nombre de
sujets qui pre´senteront des maladies a` l’avenir du fait
d’une exposition passe´e et pre´sente a` l’arsenic, en plus de
ceux qui souffrent actuellement des maladies dues a`
l’arsenic. La pe´riode de latence pour les le´sions cutane´es
provoque´es par l’arsenic (c’est-a`-dire le temps qui s’e´coule
entre la premie`re exposition et la manifestation de la
maladie), en particulier pour les ke´ratoses, est habituel-
lement de l’ordre de 10 ans. Le temps de latence pour les
cancers cutane´s et internes est de plus de 20 ans apre`s la
premie`re exposition. Les e´tudes effectue´es dans d’autres
pays ou` la population a e´te´ expose´e a` long terme a` de
l’arsenic contenu dans les nappes phre´atiques indiquent
qu’une personne sur 10 qui boit de l’eau contenant
500 mg/l d’arsenic peut finalement de´ce´der d’un des
cancers provoque´s par cette substance, notamment d’un
cancer du poumon, de la vessie ou de la peau.
L’allocation rapide de fonds et l’expansion
acce´le´re´e des interventions actuelles devraient permet-
tre de re´pondre a` cette urgence de sante´ publique. Si
l’on peut relativement simplement atte´nuer l’exposition
a` l’arsenic en fournissant de l’eau exempte d’arsenic, la
situation au Bangladesh est plus complexe du fait de la
faiblesse de l’e´conomie et de la ne´cessite´ de compter
essentiellement sur l’aide exte´rieure pour re´soudre les
proble`mes de sante´ publique. Il existe e´galement dans
ce pays des difficulte´s importantes au niveau des
communications et du transport qui constituent des
obstacles pour les programmes d’intervention et
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d’e´ducation communautaires. Ne´anmoins, contraire-
ment a` des maladies comme le paludisme, le chole´ra et
la tuberculose, qui exigent des re´ponses de sante´
publique plus complexes, la re´ponse a` une contamina-
tion de l’eau des puits tube´s est claire et nette – fournir
de l’eau exempte d’arsenic. L’arsenic est rapidement
excre´te´ dans l’urine et, pour les cas pre´coces ou be´nins,
aucun traitement spe´cifique n’est ne´cessaire. L’e´duca-
tion et la participation des communaute´s sont
indispensables pour que les interventions soient
couronne´es de succe`s et doivent eˆtre associe´es a` un
suivi des ope´rations pour confirmer que l’exposition a
cesse´.
Si l’on ignore quelle est l’e´tendue exacte du
proble`me, cela n’annule en rien la ne´cessite´ d’une re´ponse
urgente. L’e´tendue du proble`me pourra eˆtre de´termine´e
pendant qu’on y apporte une re´ponse. La sante´ de la
population est menace´e – il n’est pas question d’attendre
des enqueˆtes comple´mentaires. La de´couverte de nappes
phre´atiques contamine´es par de l’arsenic en Argentine, au
Chili, en Chine, aux Etats-Unis, en Inde, au Mexique, en
Chine (province de Taı¨wan), en Thaı¨lande et, aujourd’hui,
au Bangladesh illustre bien le fait qu’il s’agit la` d’un
proble`me mondial. Il convient donc de faire une recherche
d’arsenic dans toutes les nappes phre´atiques du monde
utilise´es pour l’eau de boisson.
Resumen
Contaminacio´n del agua de bebida con arse´nico en Bangladesh: una emergencia
de salud pu´blica
La contaminacio´n del agua frea´tica con arse´nico en
Bangladesh es, hasta la fecha, el mayor caso de
envenenamiento de una poblacio´n registrado en la
historia: millones de personas han estado expuestas al
arse´nico. En este trabajo se describe el descubrimiento
en Bangladesh de la contaminacio´n del agua de bebida
con arse´nico y se recomiendan estrategias para la
intervencio´n. A principios de los an˜os setenta se
instalaron pozos entubados para abastecer de «agua
pura» y prevenir la morbilidad y mortalidad debidas a las
enfermedades gastrointestinales. No se analizo´ la
posible contaminacio´n con arse´nico del agua de los
millones de pozos entubados que se instalaron porque a
la sazo´n no se tenı´a conciencia de ese problema.
En un estudio realizado en 1998 por el British
Geological Survey en 41 distritos se tomaron 2022
muestras de agua; se comprobo´ que en el 35% de ellas
las concentraciones de arse´nico superaban los 50 mg/l
(valor ma´ximo autorizado en Bangladesh) y en un 8,4%
se superaban los 300 mg/l. Sobre la base de la densidad
de poblacio´n de 1998, el British Geological Survey
estimo´ que el nu´mero de personas expuestas en
Bangladesh a concentraciones de arse´nico superiores a
los 50 mg/l era de unos 21 millones. Esa cifra
pra´cticamente se duplicarı´a si se adoptara la concen-
tracio´n ma´xima de 10 mg/l recomendada por la OMS.
Los efectos en la salud de ingerir agua contami-
nada con arse´nico se manifiestan lentamente. Por esa
razo´n, es importante identificar la cifra de personas que
en el futuro enfermara´n como consecuencia de una
exposicio´n pasada y persistente al arse´nico, adema´s de la
cifra de pacientes que ya han enfermado por esa causa.
El periodo de latencia de las lesiones cuta´neas
provocadas por el arse´nico (es decir, el tiempo
transcurrido desde la primera exposicio´n hasta la
manifestacio´n de la enfermedad), en particular de las
queratosis, es por regla general de unos 10 an˜os. El
periodo de latencia de los ca´nceres de la piel e internos es
de ma´s de 20 an˜os a partir del momento de la exposicio´n.
Los estudios realizados en otros paı´ses en los que la
poblacio´n ha estado expuesta largo tiempo a aguas
frea´ticas contaminadas con arse´nico indican que una de
cada 10 personas que toman agua con 500 mg/l de
arse´nico pueden acabar muriendo de ca´nceres causados
por el arse´nico, en particular de ca´nceres de pulmo´n,
vejiga y piel.
Para responder a esta emergencia de salud pu´blica
habrı´a que facilitar una ra´pida asignacio´n de fondos y la
expansio´n inmediata de las intervenciones actuales.
Aunque la exposicio´n al arse´nico puede mitigarse de
forma relativamente sencilla sin ma´s que suministrar
agua exenta de arse´nico, la situacio´n en Bangladesh se
ve complicada por la debilidad de la economı´a y por su
gran dependencia de la ayuda externa para resolver los
problemas de salud pu´blica. Las importantes dificultades
que obstaculizan las comunicaciones y el transporte
dentro de Bangladesh entorpecen tambie´n los progra-
mas comunitarios de intervencio´n y educacio´n. No
obstante, a diferencia de enfermedades como el
paludismo, el co´lera o la tuberculosis, que requieren
respuestas de salud pu´blica ma´s complejas, la respuesta
a la contaminacio´n de los pozos de agua entubados es
muy simple: suministrar agua sin arse´nico. El arse´nico se
elimina ra´pidamente por la orina y, en los casos precoces
o leves, no se precisa tratamiento especı´fico. La edu-
cacio´n y la participacio´n comunitarias son esenciales
para asegurar que las intervenciones tengan e´xito, y
deben ir acompan˜adas de un seguimiento que confirme
el final de la exposicio´n.
Se desconoce la magnitud exacta del problema,
pero no por ello es menos necesaria una respuesta de
emergencia. La envergadura se podra´ determinar en el
transcurso de la respuesta. La salud de la poblacio´n esta´
en riesgo: el socorro no puede esperar a que se realicen
ma´s estudios. El descubrimiento de que existen aguas
frea´ticas contaminadas con arse´nico en la Argentina,
Chile, China, los Estados Unidos de Ame´rica, la India,
Me´xico, la Repu´blica de China (Taiwa´n), Tailandia y,
ahora, Bangladesh evidencia que se trata de un
problema mundial. Habrı´a que analizar la presencia de
arse´nico en todas las aguas subterra´neas del mundo que
se utilizan para el consumo.
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